Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-03-14

Clinical Trial Update: Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia [Phase 3]

View source ↗

Summary

This document discusses a Phase 3 trial evaluating the efficacy and safety of co-administering telmisartan and rosuvastatin in hypertensive patients with hyperl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin (rosuvastatin)
  • Telmisartan (Telmisartan)

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Hypertension, Hyperlipidemia | Phase 3 | Status: UNKNOWN